Mesenchymal Stem Cells Mediated Drug Delivery in Tumor-Targeted Therapy

Curr Drug Deliv. 2021;18(7):876-891. doi: 10.2174/1567201817999200819140912.

Abstract

Mesenchymal Stem Cells (MSCs) possess unique properties that make them potential carriers for cancer therapy. MSCs have been documented to have low immunogenicity, positive safety in clinical trials, and the ability to selectively perform homing to inflammation and tumor sites. This review aims to introduce tumor tropism mechanism and effects of MSCs on tumor cells, and give an overview of MSCs in delivering gene therapeutic agents, oncolytic viruses and chemotherapeutics, as well as the application of MSCs-derived exosomes in tumor-targeted therapy.

Keywords: Mesenchymal stem cells; cell-mediated drug delivery; exosomes; gene therapy.; nanoparticles; tumor-targeted therapy.

Publication types

  • Review

MeSH terms

  • Drug Delivery Systems
  • Humans
  • Mesenchymal Stem Cells*
  • Neoplasms* / drug therapy
  • Pharmaceutical Preparations*

Substances

  • Pharmaceutical Preparations